ANI Pharmaceuticals Inc (ANIP)
Debt-to-capital ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Total stockholders’ equity | US$ in thousands | 428,530 | 430,798 | 455,760 | 451,963 | 432,749 | 454,711 | 434,472 | 339,482 | 338,540 | 336,675 | 336,958 | 346,094 | 358,740 | 191,403 | 191,917 | 203,712 | 195,700 | 195,100 | 191,344 | 201,171 |
Debt-to-capital ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $428,530K)
= 0.00
The debt-to-capital ratio of ANI Pharmaceuticals Inc has consistently remained at 0.00 from March 31, 2020, to December 31, 2024. This indicates that the company has not relied on debt to finance its operations or investments. A debt-to-capital ratio of 0.00 implies that the company's capital structure is mainly composed of equity, which can be seen as a positive sign as it signifies lower financial risk and less dependence on external borrowing. ANI Pharmaceuticals Inc's consistent 0.00 debt-to-capital ratio suggests a stable and conservative approach to its financial management, where the company has effectively managed its capital structure without taking on significant debt obligations.
Peer comparison
Dec 31, 2024